Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 1, 2011, Pages 29-33

  Nixon, Gillian M ^a,b   Rodda, Christine P ^a,b   Davey, Margot J ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

APNEA HYPOPNEA INDEX; CASE REPORT; CHILD; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROOCULOGRAM; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HOSPITAL DISCHARGE; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; NASOGASTRIC TUBE; OXYGEN SATURATION; PATIENT MONITORING; PLETHYSMOGRAPHY; POLYSOMNOGRAPHY; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSE OXIMETRY; SLEEP APNEA SYNDROME; TRANSCUTANEOUS CARBON DIOXIDE MONITORING; TREATMENT DURATION;

EID: 78650905235     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1445     Document Type: Conference Paper

References (25)

1. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F 1993 Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91:398-402
2. Nixon GM, Brouillette RT 2002 Sleep and breathing in Prader-Willi syndrome. Pediatr Pulmonol 34:209-217
3. Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G 1999 Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 159:1527-1532 (Pubitemid 29227864)
4. Richards A, Quaghebeur G, Clift S, Holland A, Dahlitz M, Parkes D 1994 The upper airway and sleep apnoea in the Prader-Willi syndrome. Clin Otolaryngol Allied Sci 19:193-197
5. Schlüter B, Buschatz D, Trowitzsch E, Aksu F, Andler W 1997 Respiratory control in children with Prader-Willi syndrome. Eur J Pediatr 156:65-68
6. Festen DA, de Weerd AW, van den Bossche RA, Joosten K, Hoeve H, Hokken-Koelega AC 2006 Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J Clin Endocrinol Metab 91:4911-4915
7. Hertz G, Cataletto M, Feinsilver SH, Angulo M 1993 Sleep and breathing patterns in patients with Prader-Willi syndrome (PWS): effects of age and gender. Sleep 16:366-371 (Pubitemid 23176294)
8. Miller J, Silverstein J, Shuster J, Driscoll DJ, Wagner M 2006 Shortterm effects of growth hormone on sleep abnormalities in Prader- Willi syndrome. J Clin Endocrinol Metab 91:413-417 (Pubitemid 43236903)
9. Arens R, Gozal D, Omlin KJ, Livingston FR, Liu J, Keens TG, Ward SL 1994 Hypoxic and hypercapnic ventilatory responses in Prader- Willi syndrome. J Appl Physiol 77:2224-2230 (Pubitemid 24346427)
10. Gozal D, Torres JE, Menendez AA 1996 Longitudinal assessment of hypercapnic ventilatory drive after tracheotomy in a patient with the Prader-Willi syndrome. Eur Respir J 9:1565-1568 (Pubitemid 26233806)
11. Lindgren AC, Hellström LG, Ritzén EM, Milerad J 1999 Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr 158:936-940
12. Carrel AL, Myers SE, Whitman BY, Allen DB 1999 Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. J Pediatr 134:215-221
13. Tauber M, Diene G, Molinas C, Hébert M 2008 Review of 64 cases of death in children with Prader-Willi syndrome (PWS). Am J Med Genet A 146:881-887
14. Einfeld SL, Kavanagh SJ, Smith A, Evans EJ, Tonge BJ, Taffe J 2006 Mortality in Prader-Willi syndrome. Am J Ment Retard 111:193-198
15. Stevenson DA, Anaya TM, Clayton-Smith J, Hall BD, Van Allen MI, Zori RT, Zackai EH, Frank G, Clericuzio CL 2004 Unexpected death and critical illness in Prader-Willi syndrome: report of ten individuals. Am J Med Genet A 124A:158-164
16. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H 2001 Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK health region. J Med Genet 38:792-798 (Pubitemid 33032939)
17. Schrander-Stumpel CT, Curfs LM, Sastrowijoto P, Cassidy SB, Schrander JJ, Fryns JP 2004 Prader-Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A 124A:333-338 (Pubitemid 38141373)
18. Nagai T, Obata K, Tonoki H, Temma S, Murakami N, Katada Y, Yoshino A, Sakazume S, Takahashi E, Sakuta R, Niikawa N 2005 Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 136:45-48
19. Riedl S, Blümel P, Zwiauer K, Frisch H 2005 Death in two female Prader-Willi syndrome patients during the early phase of growth hormone treatment. Acta Paediatr 94:974-977
20. Grugni G, Livieri C, Corrias A, Sartorio A, Crinò A 2005 Death during GH therapy in children with Prader-Willi syndrome: description of two new cases. J Endocrinol Invest 28:554-557
21. Van Vliet G, Deal CL, Crock PA, Robitaille Y, Oligny LL 2004 Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr 144:129-131
22. Eiholzer U, Nordmann Y, L'Allemand D 2002 Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report. Horm Res 58(Suppl 3):24-26
23. Fillion M, Deal C, Van Vliet G 2009 Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome. J Pediatr 154:230-233
24. Society AT 1996 Standards and indications for cardiopulmonary sleep studies in children. Am J Resp Crit Care Med 153: 866-878
25. Stafler P, Wallis C 2008 Prader-Willi syndrome: who can have growth hormone? Arch Dis Child 93:341-345